Growing community of inventors

Allschwil, Switzerland

Julien Hazemann

Average Co-Inventor Count = 5.17

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 8

Julien HazemannHamed Aissaoui (5 patents)Julien HazemannRomain Siegrist (5 patents)Julien HazemannChristoph Boss (4 patents)Julien HazemannPatrick Bouis (4 patents)Julien HazemannHamed Aissaoui (2 patents)Julien HazemannSylvia Richard-Bildstein (1 patent)Julien HazemannHeinz Fretz (1 patent)Julien HazemannMarkus Von Raumer (1 patent)Julien HazemannHamed Aissaoui (0 patent)Julien HazemannJulien Hazemann (5 patents)Hamed AissaouiHamed Aissaoui (38 patents)Romain SiegristRomain Siegrist (15 patents)Christoph BossChristoph Boss (59 patents)Patrick BouisPatrick Bouis (4 patents)Hamed AissaouiHamed Aissaoui (14 patents)Sylvia Richard-BildsteinSylvia Richard-Bildstein (28 patents)Heinz FretzHeinz Fretz (19 patents)Markus Von RaumerMarkus Von Raumer (15 patents)Hamed AissaouiHamed Aissaoui (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Idorsia Pharmaceuticals Ltd (4 from 77 patents)

2. Actelion Pharmaceuticals Ltd (1 from 217 patents)


5 patents:

1. 10351560 - Crystalline forms

2. 10301309 - Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators

3. 9879006 - [object Object]

4. 9850241 - Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators

5. 8697869 - 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/4/2026
Loading…